PMLS Virtual Series 2021 – Precision Oncology Fall

On Demand Now Click Here

Oct 5, 2021

Josh Bell, PhD

Director, Computational Biology, Tempus Labs

Rebecca Brandes, MS

Oncology Market Development, Companion Diagnostics, Agilent Technologies

Howard A. “Skip” Burris III, MD, FASCO, FACP

Chief Medical Officer, Sarah Cannon Research Institute

Carlee Hemphill, MS

Lead Scientist, LabCorp Drug Development

Pavan Kumar, PhD

Vice President, Translation, Kronos Bio 

Razelle Kurzrock, MD

Chief Medical Advisor & Co-founder, CureMatch; Formerly Head of Personalized Cancer Therapy, Moores Cancer Center, UCSD

Charles Lin, PhD

Senior Vice President, Biology, Kronos Bio

Mike Montalto, PhD

Chief Scientific Officer, PathAI 

Omar Perez, PhD, RAC

Head, Medical Diagnostic Strategy, AstraZeneca

Bryce Portier, MD, PhD

Medical Director, Head of Medical Affairs, Agilent Technologies

Henry Rodriguez, PhD, MS, MBA

Director, Office of Cancer Clinical Proteomics Research; Office of the Director, Division of Cancer Treatment and Diagnostics, National Cancer Institute, NIH

Dietrich A. Stephan, PhD

Chairman and Chief Executive Officer, NeuBase Therapeutics, Inc.

Greg Warner, PhD

Global Business Development Manager, Quanterix

Michael Yasiejko MBA

Executive Vice President, General Manager, Tempus Labs